2017
DOI: 10.4155/ppa-2017-0034
|View full text |Cite
|
Sign up to set email alerts
|

Patent Highlights June–July 2017

Abstract: A snapshot of noteworthy recent developments in the patent literature of relevance to pharmaceutical and medical research and development.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 45 publications
0
1
0
Order By: Relevance
“…Dichloromethane (CH 2 Cl 2 , 99,8%, PJSC "Khimprom", Novochebok-sarsk, Russia) and dimethyl sulfoxide (DMSO, 99%, "Component-Reagent", Moscow, Russia) were used. The substances studied as photostabilizers (see Figure 1), 4-methyl-2,6diisobornylphenol (DIBP) and N-isocamphylaniline (NICA), were synthesized using the methods described in [19,20]. The UV spectra of DIBP, NICA, and PLA were obtained at UV-1700 (Shimadzu, Kyoto, Japan) in chloroform solution, in the range of 200-600 nm.…”
Section: Methodsmentioning
confidence: 99%
“…Dichloromethane (CH 2 Cl 2 , 99,8%, PJSC "Khimprom", Novochebok-sarsk, Russia) and dimethyl sulfoxide (DMSO, 99%, "Component-Reagent", Moscow, Russia) were used. The substances studied as photostabilizers (see Figure 1), 4-methyl-2,6diisobornylphenol (DIBP) and N-isocamphylaniline (NICA), were synthesized using the methods described in [19,20]. The UV spectra of DIBP, NICA, and PLA were obtained at UV-1700 (Shimadzu, Kyoto, Japan) in chloroform solution, in the range of 200-600 nm.…”
Section: Methodsmentioning
confidence: 99%